Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
4051
Niagen Bioscience
NAGE
$271M
| $256K | ﹤0.01% |
70,072
+53,472
| +322% | +$168K |
|
|
LNKB
4052
DELISTED
LINKBANCORP
LNKB
| $256K | ﹤0.01% |
39,897
+13,818
| +53% | +$90.6K |
|
4053
dLocal
DLO
$4.44B
| $256K | ﹤0.01% |
31,963
+580
| +2% | +$4.7K |
|
4054
First Trust Cloud Computing ETF
SKYY
$2.92B
| $256K | ﹤0.01% |
2,500
| – | – |
|
4055
Virginia National Bankshares
VABK
$248M
| $256K | ﹤0.01% |
6,136
+4,509
| +277% | +$169K |
|
4056
Perma-Fix Environmental Services
PESI
$352M
| $255K | ﹤0.01% |
20,806
+16,544
| +388% | +$177K |
|
|
QIPT
4057
DELISTED
Quipt Home Medical
QIPT
| $255K | ﹤0.01% |
87,425
+38,635
| +79% | +$119K |
|
4058
Atossa Therapeutics
ATOS
$20.6M
| $255K | ﹤0.01% |
11,181
+8,245
| +281% | +$166K |
|
|
BCAX
4059
Bicara Therapeutics
BCAX
$1.78B
| $255K | ﹤0.01% |
+10,000
| New | +$255K |
|
4060
iShares Short Maturity Bond ETF
NEAR
$4.83B
| $255K | ﹤0.01% |
4,970
| – | – |
|
4061
Caribou Biosciences
CRBU
$145M
| $254K | ﹤0.01% |
129,839
+71,463
| +122% | +$146K |
|
4062
Sumitomo Mitsui Financial
SMFG
$164B
| $253K | ﹤0.01% |
20,000
| – | – |
|
|
LOGC
4063
DELISTED
ContextLogic
LOGC
| $252K | ﹤0.01% |
46,190
+44,982
| +3,724% | +$248K |
|
|
ADVM
4064
DELISTED
Adverum Biotechnologies
ADVM
| $252K | ﹤0.01% |
35,832
+19,965
| +126% | +$145K |
|
4065
Inhibrx
INBX
$1.2B
| $251K | ﹤0.01% |
16,055
+12,476
| +349% | +$175K |
|
4066
Orion Group Holdings
ORN
$396M
| $251K | ﹤0.01% |
43,560
+9,966
| +30% | +$76.7K |
|
|
SKE
4067
Skeena Resources
SKE
$3.3B
| $251K | ﹤0.01% |
29,696
+16,819
| +131% | +$122K |
|
4068
VanEck Agribusiness ETF
MOO
$972M
| $250K | ﹤0.01% |
3,310
| – | – |
|
4069
Invesco Solar ETF
TAN
$1.42B
| $249K | ﹤0.01% |
5,779
-45,452
| -89% | -$1.86M |
|
4070
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $249K | ﹤0.01% |
6,186
+1,787
| +41% | +$78.5K |
|
|
UBFO
4071
DELISTED
United Security Bancshares
UBFO
| $249K | ﹤0.01% |
28,576
+3,171
| +12% | +$25.2K |
|
4072
CALL
Illumina
ILMN
$31B
| $248K | ﹤0.01% |
+1,900
| New | +$234K |
|
|
BIOA
4073
BioAge Labs
BIOA
$402M
| $248K | ﹤0.01% |
+11,900
| New | +$238K |
|
4074
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.68B
| $247K | ﹤0.01% |
3,152
| – | – |
|
4075
RGC Resources
RGCO
$223M
| $247K | ﹤0.01% |
10,941
+7,879
| +257% | +$164K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.